India approves first dengue vaccine for individuals aged 4 to 60 years
Takeda’s two-dose QDENGA vaccine, approved by the Drug Controller General of India, can be administered without prior dengue screening and is designed to protect against all four dengue virus serotypes
· 7/20/2026, 10:48:18 AM· 2 min read
Takeda’s two-dose QDENGA vaccine, approved by the Drug Controller General of India, can be administered without prior dengue screening and is designed to protect against all four dengue virus serotypes
Read original story →Related stories
health
QDENGA: India’s first approved dengue vaccine
health
Why end-of-life care should include digital assets management
health
Decoding brain bleeds: evolving treatments promise encouraging results
health